Filter
4998
Filtered Results: 4998
Text search:
medicines
availability
Featured
Recommendations
477
New Publications
1355
Language
Document type
No document type
2761
Studies & Reports
960
Guidelines
658
Manuals
243
Strategic & Response Plan
204
Fact sheets
60
Training Material
57
Situation Updates
35
Resource Platforms
8
Infographics
7
Brochures
3
Online Courses
2
Countries / Regions
India
240
Global
203
Kenya
168
Ethiopia
118
South Africa
116
Uganda
110
Nepal
107
Nigeria
102
Sierra Leone
100
Malawi
99
Liberia
93
Tanzania
89
Western and Central Europe
86
Africa
84
Latin America and the Carribbean
72
Bangladesh
72
Zambia
72
Myanmar / Burma
68
Rwanda
63
Ghana
62
Ukraine
53
Syria
50
Namibia
49
Philippines
42
Congo, Democratic Republic of
42
South–East Asia Region
41
Zimbabwe
39
Senegal
31
Lesotho
30
Guinea
30
Asia
29
Eastern Europe
29
Mozambique
28
East and Southern Africa
27
Haiti
25
Venezuela
24
Cambodia
23
West and Central Africa
23
Burkina Faso
21
Botswana
21
South Sudan
20
Middle East and North Africa
19
Indonesia
18
Cameroon
17
Eastern Europe and Central Asia
16
Brazil
15
Yemen
15
Russia
14
Eswatini/ Swaziland
14
Sudan
13
Afghanistan
12
Germany
12
Pakistan
12
Benin
11
Lebanon
11
Colombia
10
Thailand
10
USA
10
Moldova
10
Jordan
9
Western Pacific Region
9
North Macedonia
8
North America
8
Somalia
8
Peru
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
Mali
7
Chile
6
Laos
6
Vietnam
6
Central African Republic
6
Iraq
6
Ecuador
6
Tajikistan
5
Kazakhstan
5
Albania
5
Kyrgyzstan
5
Niger
5
Paraguay
5
Sri Lanka
5
Poland
5
China
4
Burundi
4
Hungary
4
Southern Africa
4
Libya
4
Madagascar
4
Mexico
3
Turkey
3
Morocco
3
Jamaica
3
Mauritius
3
Belarus
3
Bolivia
3
Argentina
3
Romania
3
Angola
3
Chad
3
El Salvador
2
Serbia
2
Togo
2
Iran
2
Canada
2
Qatar
2
Bulgaria
2
Mauritania
2
Gabon
2
Turkmenistan
2
Tunisia
2
United Kingdom
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Papua New Guinea
2
Egypt
2
Palestine
2
Bhutan
2
Guatemala
2
Switzerland
1
Timor Leste/ East Timor
1
Australia
1
Gambia
1
Fiji
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Malaysia
1
Austria
1
Mongolia
1
Italy
1
Armenia
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Saudi Arabia
1
France
1
Maldives
1
Norway
1
Spain
1
Latvia
1
Nicaragua
1
Slovakia
1
Honduras
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1978
Clinical Guidelines
418
Public Health
310
Key Resources
243
Women & Child Health
228
Capacity Building
80
Pharmacy & Technologies
63
Annual Report MEDBOX
2
Toolboxes
HIV
419
Mental Health
358
COVID-19
356
TB
266
AMR
215
NTDs
164
Pharmacy
136
Planetary Health
135
NCDs
135
Caregiver
133
Rapid Response
127
Disability
127
Conflict
122
Ebola & Marburg
116
Global Health Education
71
Refugee
61
Health Financing Toolbox
54
Natural Hazards
50
Specific Hazards
22
Zika
22
Cholera
18
Polio
12
Social Ethics
11
Malaria
10
Typhoon
1
A nationwide survey of a representative sample of health facilities across public health services in all states and regions of Myanmar has been undertaken since 2014 to track Reproductive Health Commodity Security (RHCS) indicators, such as the availability of reproductive health (RH) commodities; t...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas of economically dis...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
Rehabilitation in health systems provides recommendations for Member States and other relevant stakeholders to strengthen and expand the availability of quality rehabilitation services. Currently, there is a significant unmet need for rehabilitation services and it is frequently undervalued in the h...
PLOS ONE | https://doi.org/10.1371/journal.pone.0185526 September 28, 2017
Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisboa, Portugal
DOI:https://doi.org/10.1016/S2213-2600(20)30316-7
The Lancet Respiratory Medicine
A cross-sectional descriptive study design covering all states and regions was undertaken to:
1) To assess availability, utilization and supply chain management system for RH commodities at different levels of health facilities,
2) To assess quality of RH services with emphasis on family ...
1) To assess availability, utilization and supply chain management system for RH commodities at different levels of health facilities,
2) To assess quality of RH services with emphasis on family ...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community engagement strategy. A situational analysis conducted i...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality of care they provide. The Ideal Clinic framework/dashboard sets out the standards for ...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of medi...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
